Medpace Holdings annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Medpace Holdings's operating margin was 21.14% for fiscal 2025.
View full Medpace Holdings company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 21.14% | −0.05 pp |
| 2024 | 2024-12-31 | 21.19% | +3.33 pp |
| 2023 | 2023-12-31 | 17.86% | −1.23 pp |
| 2022 | 2022-12-31 | 19.09% | +1.70 pp |
| 2021 | 2021-12-31 | 17.39% | −0.65 pp |
| 2020 | 2020-12-31 | 18.04% | +3.26 pp |
| 2019 | 2019-12-31 | 14.78% | +0.44 pp |
| 2018 | 2018-12-31 | 14.34% | −0.53 pp |
| 2017 | 2017-12-31 | 14.87% | +2.42 pp |
| 2016 | 2016-12-31 | 12.45% | +6.72 pp |
| 2015 | 2015-12-31 | 5.73% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 20.76% | −0.18 pp |
| Q1 2026 | 2026-03-31 | 20.03% | −0.30 pp |
| Q4 2025 | 2025-12-31 | 21.63% | −1.73 pp |
| Q3 2025 | 2025-09-30 | 21.49% | +0.44 pp |
| Q2 2025 | 2025-06-30 | 20.94% | +1.03 pp |
| Q1 2025 | 2025-03-31 | 20.32% | −0.04 pp |
| Q4 2024 | 2024-12-31 | 23.37% | +5.85 pp |
| Q3 2024 | 2024-09-30 | 21.05% | +3.81 pp |
| Q2 2024 | 2024-06-30 | 19.91% | +2.90 pp |
| Q1 2024 | 2024-03-31 | 20.36% | +0.50 pp |
| Q4 2023 | 2023-12-31 | 17.52% | −1.87 pp |
| Q3 2023 | 2023-09-30 | 17.24% | −3.04 pp |
| Q2 2023 | 2023-06-30 | 17.01% | −0.14 pp |
| Q1 2023 | 2023-03-31 | 19.86% | +0.46 pp |
| Q4 2022 | 2022-12-31 | 19.39% | +1.62 pp |
| Q3 2022 | 2022-09-30 | 20.28% | +2.11 pp |
| Q2 2022 | 2022-06-30 | 17.15% | +1.90 pp |
| Q1 2022 | 2022-03-31 | 19.40% | +1.09 pp |
| Q4 2021 | 2021-12-31 | 17.78% | −3.40 pp |
| Q3 2021 | 2021-09-30 | 18.17% | −1.98 pp |
| Q2 2021 | 2021-06-30 | 15.25% | +0.56 pp |
| Q1 2021 | 2021-03-31 | 18.31% | +2.93 pp |
| Q4 2020 | 2020-12-31 | 21.18% | +5.46 pp |
| Q3 2020 | 2020-09-30 | 20.15% | +6.28 pp |
| Q2 2020 | 2020-06-30 | 14.70% | −1.77 pp |
| Q1 2020 | 2020-03-31 | 15.38% | +2.48 pp |
| Q4 2019 | 2019-12-31 | 15.71% | −0.25 pp |
| Q3 2019 | 2019-09-30 | 13.87% | −1.15 pp |
| Q2 2019 | 2019-06-30 | 16.47% | +2.75 pp |
| Q1 2019 | 2019-03-31 | 12.90% | +0.56 pp |
| Q4 2018 | 2018-12-31 | 15.96% | +8.92 pp |
| Q3 2018 | 2018-09-30 | 15.02% | −0.53 pp |
| Q2 2018 | 2018-06-30 | 13.72% | −1.61 pp |
| Q1 2018 | 2018-03-31 | 12.34% | +0.43 pp |
| Q4 2017 | 2017-12-31 | 7.04% | −4.66 pp |
| Q3 2017 | 2017-09-30 | 15.54% | +2.22 pp |
| Q2 2017 | 2017-06-30 | 15.33% | +2.40 pp |
| Q4 2016 | 2016-12-31 | 11.91% | +4.10 pp |
| Q3 2016 | 2016-09-30 | 11.70% | — |
| Q2 2016 | 2016-06-30 | 13.32% | — |
| Q1 2016 | 2016-03-31 | 12.92% | — |
| Q3 2015 | 2015-09-30 | 7.81% | — |
Over the last five reported fiscal years, Medpace Holdings's operating margin increased from 18.04% to 21.14%, a change of +3.10 percentage points. The latest reported quarter, Q2 2026, shows 20.76%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medpace Holdings filings at SEC.gov ↗